Related Experiment Videos
Mortality from renal diseases in Finland
J Varis1, H Oksa, A Pasternack
1Institute of Clinical Sciences, University of Tampere, Finland.
Scandinavian Journal of Urology and Nephrology
|January 1, 1988
Summary
Renal disease mortality in Finland rose until 1962, then declined due to treatments like dialysis and transplantation. Wider access to these interventions could have saved more lives, particularly for those under 70.
Area of Science:
- Nephrology
- Epidemiology
- Public Health
Background:
- Mortality from renal disease in Finland exhibited a concerning rise in the mid-20th century.
- The role of analgesic overuse, specifically phenacetin, was hypothesized as a contributing factor to increased renal deaths.
- Advancements in renal replacement therapies have shown promise in mitigating mortality rates.
Purpose of the Study:
- To analyze trends in renal disease mortality in Finland from 1951 to 1982.
- To investigate potential factors influencing these mortality trends, including medical interventions.
- To assess the impact of renal dialysis and transplantation on survival rates.
Main Methods:
- Retrospective analysis of mortality data related to renal disease in Finland.
- Examination of temporal trends in mortality rates over a 30-year period.
- Correlation of mortality data with the availability and utilization of renal replacement therapies.
Main Results:
- Overall renal disease mortality increased until 1962, followed by a subsequent decrease.
- While phenacetin use was suspected, direct evidence linking it to the mortality increase was not definitive.
- Renal dialysis and transplantation significantly reduced mortality rates.
- In the early 1980s, a substantial proportion (50%) of renal disease deaths in individuals under 70 occurred without these treatments.
Conclusions:
- Renal replacement therapies have dramatically improved survival for patients with renal disease.
- The potential for further mortality reduction exists through unrestricted access to dialysis and transplantation.
- Public health strategies should focus on ensuring equitable access to advanced renal care to prevent premature deaths.